Goldman upgraded MetLife from Neutral to Buy and set a new price target of $80.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/9/2024 | $97.00 | Buy | TD Cowen |
| 9/5/2024 | $91.00 | Overweight | Barclays |
| 1/8/2024 | $80.00 | Neutral → Buy | Goldman |
| 11/17/2023 | $71.00 | Overweight | Barclays |
| 10/5/2023 | $71.00 | Hold | Deutsche Bank |
| 9/14/2023 | $58.00 → $72.00 | Hold → Buy | Jefferies |
| 1/9/2023 | $80.00 → $78.00 | Buy → Neutral | Goldman |
| 12/9/2022 | $86.00 → $82.00 | Buy → Hold | Jefferies |
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, MetLife, Inc., and head of MetLife Investment Management, has provided a third quarter 2024 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030606174/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help indivi
MetLife, Inc. (NYSE:MET) today announced its third quarter 2024 results. Third Quarter Results Summary Net income of $1.3 billion, or $1.81 per share, compared to net income of $422 million, or $0.56 per share, in the third quarter of 2023. Adjusted earnings of $1.4 billion, or $1.95 per share, compared to adjusted earnings of $1.5 billion, or $1.97 per share, in the third quarter of 2023. Book value of $39.02 per share, up 33 percent from $29.34 per share at September 30, 2023. Book value, excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA), of $54.72 per share, up 3 percent from $53.00 per share at September 30, 2023.
MetLife, Inc. (NYSE:MET) today announced that its board of directors has declared a fourth quarter 2024 common stock dividend of $0.545 per share. The dividend will be payable on Dec. 16, 2024, to shareholders of record as of Nov. 5, 2024. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and t
The Human Animal Bond Research Institute (HABRI) and MetLife Pet Insurance Solutions LLC ("MetLife Pet"), one of the world's leading financial services companies, today announced a collaboration to advance their shared goal of strengthening the human-animal bond through research, education and advocacy. "At MetLife Pet Insurance, we are focused on ensuring all pet parents' have access to veterinary resources so they can confidently care for their pets and that our four-legged family members receive the care they need," said Brian Jorgensen, CEO of MetLife Pet Insurance. "We are committed to protecting and supporting the relationship between people and their pets, which is in complete align
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, MetLife, Inc., and head of MetLife Investment Management, has provided a third quarter 2024 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030606174/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help indivi
MetLife, Inc. (NYSE:MET) today announced its third quarter 2024 results. Third Quarter Results Summary Net income of $1.3 billion, or $1.81 per share, compared to net income of $422 million, or $0.56 per share, in the third quarter of 2023. Adjusted earnings of $1.4 billion, or $1.95 per share, compared to adjusted earnings of $1.5 billion, or $1.97 per share, in the third quarter of 2023. Book value of $39.02 per share, up 33 percent from $29.34 per share at September 30, 2023. Book value, excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA), of $54.72 per share, up 3 percent from $53.00 per share at September 30, 2023.
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
10-Q - METLIFE INC (0001099219) (Filer)
8-K - METLIFE INC (0001099219) (Filer)
144 - METLIFE INC (0001099219) (Subject)
Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such
MetLife's John Wilson takes over for Kramden founder, who headed the board for two decades As a part of MetLife's, Inc. (NYSE:MET) global strategy to increase diversity in Science, Technology, Engineering and Math (STEM), the company today announced that John Wilson was named chair of the Board of Kramden Institute, a North Carolina non-profit that provides technology and training to bridge the digital divide. Wilson takes over the chair position from the organization's founder, Mark Dibner, who has overseen Kramden's growth for the last 20 years. "We are blessed to have a board of directors passionate about technology and social impact," said Cyndy Yu-Robinson, Kramden Executive Direct
Sofía Belmar to take new role with Latin America regional team and be succeeded by Mario Valdes, who currently oversees six operations in Central and Eastern Europe These changes reinforce MetLife's commitment to cross-region talent development and succession planning After six years of successfully leading MetLife's operation in Mexico – the company's third-largest global operation – Sofía Belmar-Berumen will be taking a new regional role as Head of Business Development and Transformation, Latin America. Belmar's leadership and business acumen have been critical for MetLife Mexico to become the leading player in the local insurance industry. A prominent thought leader, she is the first
TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00
Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00
Goldman upgraded MetLife from Neutral to Buy and set a new price target of $80.00
Citigroup analyst Michael Ward maintains MetLife (NYSE:MET) with a Buy and raises the price target from $83 to $89.
Throughout the last three months, 9 analysts have evaluated MetLife (NYSE:MET), offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 6 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 3 0 0 0 2M Ago 1 0 0 0 0 3M Ago 0 3 0 0 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $84.0, a high estimate of $86.00, and a low estimate of $80.00. Observing a 0.13% increase, the current average has risen from
Jefferies analyst Suneet Kamath maintains MetLife (NYSE:MET) with a Buy and raises the price target from $83 to $86.